Announcement on Accounting Firm Change
Filed with SSE · · 5 pages · Chinese
Shanghai Allist Pharmaceuticals Co. Ltd. on 6ix
Earlier from Shanghai Allist Pharmaceuticals
- Announcement on Attending Collective Q3 Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2024
- Announcement on the Result of Shareholding Reduction by Shareholders and the Change in Equity Reaching 1%
- Report for Q3 2024
- Announcement on Change of Sponsor Representative
- Announcement on Voluntary Disclosure of Obtaining the Drug Clinical Trial Approval Notification for AST2303 Tablets
Later from Shanghai Allist Pharmaceuticals
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
- Announcement on Resolution of the 10th Meeting of the 2nd Board of Supervisors
- Announcement on Voluntary Disclosure of Obtaining Notice of Drug Clinical Trial Approval for New Indications of Furmonertinib
- Annual Earnings Preannouncement for 2024
- Announcement on Preliminary Earnings Estimate for 2024
Follow Shanghai Allist Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Allist Pharmaceuticals